In a study published this week in JCI Insight, Dr. Ankit Bharat, director of the Northwestern Medicine Canning Thoracic Institute, laid out how abnormal cells emerge and work to cause lung damage and ...
‘Chronic lung-transplant rejection has been a black box.’ New study gives answers, drug targets.
Study found which abnormal cells talk to each other in harmful ways and perpetuate lung damage Scientists are already exploring therapeutic strategies based on this study’s discoveries Treatments also ...
More than 50% of lung-transplant recipients experience a rejection of their new lung within five years of receiving it, yet the reason why this is such a prevalent complication has remained a medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results